Literature DB >> 2431817

Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy.

T H Rea, J Y Shen, R L Modlin.   

Abstract

Epidermal changes, Ia expression on keratinocytes, Langerhans cell hyperplasia and lymphocyte infiltration were sought in skin lesions of leprosy: 15 borderline tuberculoid (BT), six borderline lepromatous (BL), 17 lepromatous (LL), 13 erythema nodosum leprosum (ENL), six Lucio reactions and nine reversal reactions. All three changes were well developed in BT and reversal reactions. ENL showed well developed keratinocyte Ia and Langerhans cell hyperplasia, but little lymphocytic infiltration. LL and Lucio tissues had some Langerhans cell hyperplasia but little or no keratinocyte Ia or lymphocytic infiltration. BL tissues were so diverse as to suggest two distinct subgroups. These findings are consistent with the hypothesis that keratinocyte Ia expression is an immunohistological sign of a cell-mediated immune (CMI) response. However, the Ia keratinocyte expression found in BL and ENL tissues appears contrary to the undifferentiated macrophages and numerous bacilli found in the lesions. Thus, if a sign of CMI, keratinocyte Ia expression is not a measure of the effectiveness of the response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431817      PMCID: PMC1542316     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Cell mediated and humoral immunity in "reversal reactions".

Authors:  R S Barnetson; G Bjune; J M Pearson; G Kronvall
Journal:  Int J Lepr Other Mycobact Dis       Date:  1976 Jan-Jun

Review 2.  Current concepts in the immunology of leprosy.

Authors:  T H Rea; N E Levan
Journal:  Arch Dermatol       Date:  1977-03

3.  Ia antigen expression on human epidermal Langerhans cells.

Authors:  G Rowden; M G Lewis; A K Sullivan
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

4.  Significance of variations within the lepromatous group.

Authors:  D S Ridley; M F Waters
Journal:  Lepr Rev       Date:  1969-07       Impact factor: 0.537

Review 5.  Origin and function of epidermal Langerhans cells.

Authors:  G Stingl; K Tamaki; S I Katz
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  Variations in dinitrochlorobenzene responsivity in untreated leprosy: evidence of a beneficial role for anergy.

Authors:  T H Rea; N E Levan
Journal:  Int J Lepr Other Mycobact Dis       Date:  1980-06

7.  Expression of Ia antigen on epidermal keratinocytes is a consequence of cellular immunity.

Authors:  A J Suitters; I A Lampert
Journal:  Br J Exp Pathol       Date:  1982-04

8.  Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease.

Authors:  I A Lampert; A J Suitters; P M Chisholm
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

9.  In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.

Authors:  R L Modlin; V Mehra; R Jordan; B R Bloom; T H Rea
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

10.  Defect in the generation of cytotoxic T cells in lepromatous leprosy.

Authors:  J L Stach; M Strobel; F Fumoux; J F Bach
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

View more
  10 in total

Review 1.  T cell and cytokine patterns in leprosy skin lesions.

Authors:  P A Sieling; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Reactions following completion of 1 and 2 year multidrug therapy (MDT).

Authors:  Ma Victoria F Balagon; Robert H Gelber; Rodolfo M Abalos; Roland V Cellona
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

Review 3.  Immunopathology of leprosy granulomas.

Authors:  R L Modlin; T H Rea
Journal:  Springer Semin Immunopathol       Date:  1988

4.  Expression of major histocompatibility complex class I and class II antigens in human Schwann cell cultures and effects of infection with Mycobacterium leprae.

Authors:  N M Samuel; R Mirsky; J M Grange; K R Jessen
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

5.  Expression of adhesion molecules in leprosy lesions.

Authors:  L Sullivan; S Sano; C Pirmez; P Salgame; C Mueller; F Hofman; K Uyemura; T H Rea; B R Bloom; R L Modlin
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy.

Authors:  J Arnoldi; J Gerdes; H D Flad
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

7.  Autophagy links antimicrobial activity with antigen presentation in Langerhans cells.

Authors:  Angeline Tilly Dang; Rosane Mb Teles; Phillip T Liu; Aaron Choi; Annalisa Legaspi; Euzenir N Sarno; Maria T Ochoa; Kislay Parvatiyar; Genhong Cheng; Michel Gilliet; Barry R Bloom; Robert L Modlin
Journal:  JCI Insight       Date:  2019-04-18

8.  Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.

Authors:  Megan S Inkeles; Rosane Mb Teles; Delila Pouldar; Priscila R Andrade; Cressida A Madigan; David Lopez; Mike Ambrose; Mahdad Noursadeghi; Euzenir N Sarno; Thomas H Rea; Maria T Ochoa; M Luisa Iruela-Arispe; William R Swindell; Tom Hm Ottenhoff; Annemieke Geluk; Barry R Bloom; Matteo Pellegrini; Robert L Modlin
Journal:  JCI Insight       Date:  2016-09-22

9.  Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization.

Authors:  C L Cooper; C Mueller; T A Sinchaisri; C Pirmez; J Chan; G Kaplan; S M Young; I L Weissman; B R Bloom; T H Rea; R L Modlin
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

Review 10.  Innate Immune Responses in Leprosy.

Authors:  Roberta Olmo Pinheiro; Veronica Schmitz; Bruno Jorge de Andrade Silva; André Alves Dias; Beatriz Junqueira de Souza; Mayara Garcia de Mattos Barbosa; Danuza de Almeida Esquenazi; Maria Cristina Vidal Pessolani; Euzenir Nunes Sarno
Journal:  Front Immunol       Date:  2018-03-28       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.